Structural rearrangements of chromosome 3 in 57 patients with acute myeloid leukemia: clinical, hematological and cytogenetic features.

[1]  E. Wattel,et al.  Continuous-infusion carboplatin in combination with idarubicin or mitoxantrone for high-risk acute myeloid leukemia: a randomised phase II study. , 1999, Leukemia & lymphoma.

[2]  J. Yokota,et al.  Activation of EVI1 transcripts with chromosomal translocation joining the TCRVβ locus and the EVI1 gene in human acute undifferentiated leukemia cell line (Kasumi-3) with a complex translocation of der(3)t(3;7;8) , 1999, Leukemia.

[3]  R. Willemze,et al.  Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia , 1999, Leukemia.

[4]  L. Koulischer,et al.  Translocation (2;3)(p21;q26) as the sole anomaly in a case of primary myelofibrosis. , 1999, Cancer genetics and cytogenetics.

[5]  K Wheatley,et al.  The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. , 1998, Blood.

[6]  Y. Kwong,et al.  Translocation (3;5)(q21;q34) in erythroleukemia: a molecular and in situ hybridization study. , 1998, Cancer genetics and cytogenetics.

[7]  G. Nucifora.  The EVI1 gene in myeloid leukemia , 1997, Leukemia.

[8]  P. Marynen,et al.  Fluorescence in situ hybridization analysis of t(3; 12)(q26; p13): a recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes. , 1996, Blood.

[9]  A. A. Gordeeva,et al.  Translocation (2;3)(p13;q26) in two cases of myeloid malignancies. Acute myeloblastic leukemia (M2) and blastic phase of chronic myeloid leukemia. , 1996, Cancer genetics and cytogenetics.

[10]  S. Raimondi,et al.  The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. , 1996, Oncogene.

[11]  J. Pedersen‐Bjergaard,et al.  Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. , 1995, Blood.

[12]  B. Bain,et al.  Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study , 1995, British journal of haematology.

[13]  R. Gascoyne,et al.  Acute leukemia with structural rearrangements of chromosome 3. , 1995, Leukemia & lymphoma.

[14]  R. Berger,et al.  Translocation (2;3)(p22;q28) is associated with myeloid disorders. , 1995, Cancer genetics and cytogenetics.

[15]  J. Yokota,et al.  Identification of a breakpoint cluster region 3' of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26). , 1994, Blood.

[16]  P. Greenberg,et al.  Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. , 1994, Blood.

[17]  E. Thiel,et al.  Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26). , 1994, Leukemia.

[18]  B. Johansson,et al.  Translocation (3;21)(q26;q22) in therapy-related myelodysplasia following drugs targeting DNA-topoisomerase II combined with alkylating agents, and in myeloproliferative disorders undergoing spontaneous leukemic transformation. , 1994, Cancer genetics and cytogenetics.

[19]  J. Rowley,et al.  Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  X. Thomas,et al.  Prospective genetically randomized comparison between intensive postinduction chemotherapy and bone marrow transplantation in adults with newly diagnosed acute myeloid leukemia. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  R. Gascoyne,et al.  Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3 , 1993, British journal of haematology.

[22]  C. Sebban,et al.  Continuous-infusion daunorubicin and carboplatin for high-risk acute myeloid leukemia in the elderly. , 1992, Leukemia.

[23]  J. Ihle,et al.  Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  E. Solary,et al.  New case of t(3;17)(q26;q22) as an additional change in a Philadelphia-positive chronic myelogenous leukemia in acceleration. , 1992, Cancer genetics and cytogenetics.

[25]  D. Mühlematter,et al.  Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndrome. , 1992, Cancer genetics and cytogenetics.

[26]  J. Rowley,et al.  Recurring chromosome abnormalities in leukemia and lymphoma. , 1990, Seminars in hematology.

[27]  A. de la Chapelle,et al.  Cytogenetic studies of 103 patients with acute myelogenous leukemia in relapse. , 1989, Cancer genetics and cytogenetics.

[28]  C. Bloomfield,et al.  t(1;3)(p36;q21) in acute nonlymphocytic leukemia: a new cytogenetic- clinicopathologic association , 1985 .

[29]  C. Mecucci,et al.  Translocation t(3;17)(q26;q22): a marker of acute disease in myeloproliferative disorders? , 1984, Cancer genetics and cytogenetics.

[30]  B. Mendelow,et al.  Chromosome 3 abnormalities in acute nonlymphocytic leukemia (ANLL) with abnormal thrombopoiesis: report of three patients with a new inversion anomaly and a further case of homologous translocation , 1982 .

[31]  J. Rowley,et al.  Acute myelogenous leukemia and thrombocythemia associated with an abnormality of chromosome No. 3 , 1979 .

[32]  H. Gralnick,et al.  Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group , 1976, British journal of haematology.

[33]  J. Rowley,et al.  Acute nonlymphocytic leukemia in adults: correlations with Q-banded chromosomes. , 1976, Blood.

[34]  J. Rowley,et al.  Chromosomal banding patterns in acute nonlymphocytic leukemia. , 1976, Blood.

[35]  C. Spurr,et al.  Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. , 1968, Blood.

[36]  S. Wyard,et al.  THE NATURAL DURATION OF CANCER , 1925, Canadian Medical Association journal.

[37]  P. Greenberg,et al.  Expression of EVIl in Myelodysplastic Syndromes and Other Hematologic Malignancies Without 3 q 26 Translocations , 2002 .

[38]  J. Yokota,et al.  A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells. , 2000, Blood.

[39]  H. Dombret,et al.  A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia. , 1999, Blood.

[40]  P. Fenaux,et al.  Place de la double induction dans le traitement des leucémies aiguës myéloblastiques de l'adulte : résultats intermédiaires du protocole LAM90 , 1994 .

[41]  S. Raimondi,et al.  The human Evi-1 gene is located on chromosome 3q24-q28 but is not rearranged in three cases of acute nonlymphocytic leukemias containing t(3;5)(q25;q34) translocations. , 1990, Oncogene research.

[42]  J. Winter,et al.  t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. , 1990, Blood.

[43]  S. Raimondi,et al.  Clinicopathologic manifestations and breakpoints of the t(3;5) in patients with acute nonlymphocytic leukemia. , 1989, Leukemia.

[44]  E. Gehan,et al.  Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome. , 1988, Leukemia.

[45]  B. Mendelow,et al.  Chromosome 3 abnormalities in acute nonlymphocytic leukemia (ANLL) with abnormal thrombopoiesis: report of three patients with a "new" inversion anomaly and a further case of homologous translocation. , 1982, Blood.